| Triplet therapy, transplantation, and maintenance until progression in myeloma PG Richardson, SJ Jacobus, EA Weller, H Hassoun, S Lonial, NS Raje, ... New England Journal of Medicine 387 (2), 132-147, 2022 | 232 | 2022 |
| Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review A Russ, AB Hua, WR Montfort, B Rahman, IB Riaz, MU Khalid, JS Carew, ... Blood reviews 32 (6), 480-489, 2018 | 169 | 2018 |
| Patterns of pancytopenia patients in a general medical ward and a proposed diagnostic approach O Ishtiaq, HZ Baqai, F Anwer, N Hussain Journal of Ayub Medical College Abbottabad 16 (1), 2004 | 159 | 2004 |
| Significant risk of graft-versus-host disease with exposure to checkpoint inhibitors before and after allogeneic transplantation A Ijaz, AY Khan, SU Malik, W Faridi, MA Fraz, M Usman, MJ Tariq, S Durer, ... Biology of Blood and Marrow Transplantation 25 (1), 94-99, 2019 | 156 | 2019 |
| A review of autologous stem cell transplantation in lymphoma U Zahid, F Akbar, A Amaraneni, M Husnain, O Chan, IB Riaz, A McBride, ... Current hematologic malignancy reports 12, 217-226, 2017 | 117 | 2017 |
| Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system HM Babiker, A McBride, M Newton, LM Boehmer, AG Drucker, M Gowan, ... Critical reviews in oncology/hematology 126, 186-200, 2018 | 101 | 2018 |
| Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review F Anwer, AA Shaukat, U Zahid, M Husnain, A McBride, D Persky, M Lim, ... Immunotherapy 9 (2), 123-130, 2017 | 97 | 2017 |
| Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance RM Usman, F Razzaq, A Akbar, AA Farooqui, A Iftikhar, A Latif, H Hassan, ... Asia‐Pacific Journal of Clinical Oncology 17 (3), 193-208, 2021 | 89 | 2021 |
| Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results S Mailankody, JV Matous, S Chhabra, M Liedtke, S Sidana, OO Oluwole, ... Nature medicine 29 (2), 422-429, 2023 | 88 | 2023 |
| Brentuximab vedotin for treatment of non-Hodgkin lymphomas: a systematic review GK Berger, A McBride, S Lawson, K Royball, S Yun, K Gee, IB Riaz, ... Critical reviews in oncology/hematology 109, 42-50, 2017 | 76 | 2017 |
| Relapse prevention with tyrosine kinase inhibitors after allogeneic transplantation for philadelphia chromosome–positive acute lymphoblast leukemia: A systematic review Z Warraich, P Tenneti, T Thai, A Hubben, H Amin, A McBride, S Warraich, ... Biology of Blood and Marrow Transplantation 26 (3), e55-e64, 2020 | 66 | 2020 |
| Waldenström macroglobulinemia: review of pathogenesis and management S Yun, AC Johnson, ON Okolo, SJ Arnold, A McBride, L Zhang, RC Baz, ... Clinical Lymphoma Myeloma and Leukemia 17 (5), 252-262, 2017 | 58 | 2017 |
| Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy KR Kelly, CM Espitia, W Zhao, K Wu, V Visconte, F Anwer, CM Calton, ... Leukemia 32 (1), 230-233, 2018 | 56 | 2018 |
| Treatment of relapsed multiple myeloma: Evidence-based recommendations C Durer, S Durer, S Lee, R Chakraborty, MN Malik, A Rafae, MA Zar, ... Blood Reviews 39, 100616, 2020 | 55 | 2020 |
| Prevalence of transfusion transmissible infections in beta-thalassemia major patients in Pakistan: a systematic review H Ehsan, A Wahab, F Anwer, R Iftikhar, MN Yousaf Cureus 12 (8), 2020 | 51 | 2020 |
| Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies R Iftikhar, F Anwer, K Neupane, A Rafae, SK Mahmood, T Ghafoor, ... Blood reviews 47, 100772, 2021 | 43 | 2021 |
| Universal updated phase 1 data validates the feasibility of allogeneic anti-BCMA ALLO-715 therapy for relapsed/refractory multiple myeloma S Mailankody, M Liedtke, S Sidana, JV Matous, S Chhabra, OO Oluwole, ... Blood 138, 651, 2021 | 39 | 2021 |
| Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes RT Swords, J Watts, HP Erba, JK Altman, M Maris, F Anwer, Z Hua, ... Blood cancer journal 7 (2), e520-e520, 2017 | 39 | 2017 |
| Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review A Mushtaq, V Kapoor, A Latif, A Iftikhar, U Zahid, A McBride, I Abraham, ... Critical reviews in oncology/hematology 125, 1-11, 2018 | 38 | 2018 |
| The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine ST Nawrocki, Y Han, V Visconte, B Przychodzen, CM Espitia, J Phillips, ... Leukemia 33 (12), 2971-2974, 2019 | 37 | 2019 |
Jack Khouri, MDCleveland ClinicVerified email at ccf.org
